scholarly journals Metabolic health during a randomized controlled lifestyle intervention in women with PCOS

2021 ◽  
Author(s):  
Alexandra Dietz de Loos ◽  
Geranne Jiskoot ◽  
Annemerle Beerthuizen ◽  
Jan Busschbach ◽  
Joop Laven

Context Women with polycystic ovary syndrome (PCOS) have an increased risk of metabolic syndrome (MetS). Both PCOS and MetS are associated with excess weight. Objective To examine the effect of a three-component lifestyle intervention (LSI) with or without short message service (SMS+ or SMS- respectively) on the prevalence and severity of MetS and metabolic parameters, compared to care as usual (CAU). Design Randomized controlled trial. Methods Women diagnosed with PCOS and a BMI >25 kg/m² (n = 183) were either assigned to a one-year three-component (cognitive behavioural therapy, diet, exercise) LSI, with or without SMS support, or to CAU which provided weight loss advice only. Main outcome measures included changes in the prevalence of MetS, the continuous MetS severity z-score (cMetS z-score), metabolic parameters, and the impact of weight loss. Results After one year the decrease in the cMetS z-score was greater in the SMS+ group than the CAU group (-0.39, p=0.015). The prevalence of MetS changed with -21.6% (p=0.037), -16.5% (p=0.190) and +7.0% (p=0.509) in both LSI groups and CAU group, respectively. A post hoc analysis for both LSI groups combined vs CAU resulted in a MetS difference of -25.9% (p=0.046). Moreover, weight loss per se resulted in significant favourable effects on all metabolic parameters. Conclusions This three-component lifestyle intervention was more successful in improving metabolic health compared to CAU. Therefore we recommend this intervention to women with PCOS and excess weight, provided that a clinically relevant weight loss is being pursued.

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
A Dietz de Loos ◽  
G Jiskoot ◽  
A Beerthuizen ◽  
J Van Busschbach ◽  
J Laven

Abstract Study question What is the impact of a three-component lifestyle intervention on the prevalence and severity of metabolic syndrome (MetS) in women with polycystic ovary syndrome (PCOS)? Summary answer This three-component lifestyle intervention was more successful in improving metabolic health in reproductive-aged women with PCOS compared to minimal treatment. What is known already Women with PCOS have increased risk of MetS, and both PCOS and MetS are associated with excess weight. Moreover, obesity exacerbates many of the metabolic abnormalities associated with PCOS. Multi-component lifestyle interventions are the first line treatment to improve weight. Previous studies in women with PCOS have described improvements in waist circumference, cholesterol, low-density lipoprotein and fasting insulin after (one-, or two-component) lifestyle interventions. However little is known about changes in the prevalence of MetS, continuous MetS severity z-score (cMetS z-score), different metabolic parameters and the effects of changes in weight per se after three-component lifestyle interventions. Study design, size, duration An randomized controlled trial (RCT) was performed and participants were either assigned to a one-year three-component (cognitive behavioural therapy, diet, exercise) lifestyle intervention (LSI), with or without additional short message service (SMS) support (SMS+ and SMS- respectively), both receiving 20 group sessions, or to care as usual (CAU, control) which consisted of advice to lose weight by methods of their own choosing. Overall, 183 women were included between August 2010 and March 2016. Participants/materials, setting, methods Women diagnosed with PCOS according to the Rotterdam 2003 criteria, aged 18-38 years, having a wish to conceive and a BMI >25 kg/m² were included at the Erasmus MC, The Netherlands. Outcome variables were evaluated every three months and included anthropometric measurements, ultrasound and an endocrine assessment. Multilevel linear and logistic regression was applied for longitudinal analyses. Main results and the role of chance The cMetS severity z-score decreased more in the SMS+ group vs CAU after one year (-0.39, p = 0.015). MetS changed with -21.6% (p = 0.037), -16.5% (p = 0.190) and +7.0% (p = 0.509) within the SMS-, SMS+ and CAU group respectively. Moreover, a post hoc analysis on the prevalence of MetS for both LSI groups combined vs CAU resulted in a difference of -25.9% (p = 0.046) after one year in favour of the LSI groups. Weight loss per se resulted in significant favourable effects on all metabolic parameters. Limitations, reasons for caution Dropout during lifestyle interventions is unfortunately a common phenomenon, and our RCT also suffered from considerable discontinuation rates which is a limitation. Therefore, we selected a statistical method (multilevel regression modelling) specifically designed to deal with such missing values. Wider implications of the findings These findings confirm that three-component lifestyle interventions aiming at a 5-10% weight loss should be recommended for all women with PCOS in order to improve metabolic health during their reproductive lifespan. Trial registration number NTR2450


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 3182-3182 ◽  
Author(s):  
Kristen M. Sanfilippo ◽  
Tracey Beason ◽  
Su-Hsin Chang ◽  
Suhong Luo ◽  
Graham A Colditz ◽  
...  

Abstract Abstract 3182 Background: Two thirds of the adult population in the United States (US) is either overweight or obese based on BMI. Elevated BMI has been associated with an increased risk of death from hematologic malignancies, including MM. This occurs through modification of MM disease incidence, survival after diagnosis, or a combination of the two. Limited data is available on the impact of BMI at diagnosis on mortality in patients with MM. We used a retrospective cohort to evaluate the impact of BMI at diagnosis on survival patterns in MM patients treated at US VHA hospitals. Methods: The VHA Central Cancer Registry was used to identify electronic records of 5,013 patients diagnosed with MM between October 1998 and December 2009. To minimize misclassification bias (remove patients with monoclonal gammopathy and smoldering myeloma) we excluded patients who did not receive therapy within 6 months of diagnosis of MM. Patients without weight and height measurements within 1 month of diagnosis were also excluded, resulting in an analytic cohort of 2,968 patients. Results: Table 1 demonstrates baseline characteristics of the analytic cohort, including stratification by BMI. Based on BMI at time of diagnosis, Cox modeling showed a reduction in mortality for overweight (BMI 25 to <30) and obese (BMI ≥30) patients, (hazard ratio for death [HR], 0.82; 95% CI: 0.75–0.91 and 0.75; 95% CI: 0.67–0.84, respectively), compared to normal weight patients (BMI 18.5 to <25) after controlling for age and co-morbidities. Underweight (BMI <18.5) was associated with a higher mortality compared to normal weight (HR, 1.64; 95% CI: 1.30–2.08). To examine the potential confounder of disease related weight loss, we obtained weight information one year before diagnosis in a subset of the analytic cohort (n=1,983). Patients who lost more than 10% of their body weight over the year before diagnosis, compared to those who did not, had higher mortality (HR, 1.58; 95% CI: 1.41–1.78). When analyzed by BMI one year before diagnosis, the association between obesity and decreased mortality was lost (HR: 0.93, 95% CI 0.81–1.07), while patients who were overweight had only borderline significance in mortality reduction (HR: 0.87, 95% CI 0.76–0.99). Conclusion: MM patients who are overweight or obese at the time of diagnosis had decreased mortality compared to those who are normal-weight. In an effort to understand the influence of disease-related weight loss on this observation, we examined weight one year before diagnosis and found the association was no longer present in obese patients and only borderline present in overweight patients. This coupled with the observation that patients who lost 10% or more of their body weight in the year leading up to diagnosis had increased mortality (HR 1.58) suggests that disease-related weight loss is a major driver of the decreased survival seen in patients with a lower BMI at diagnosis. To our knowledge, this is the first study demonstrating that disease related weight loss in the time leading up to diagnosis is associated with decreased survival in MM. The mechanisms by which disease related weight loss drives a poorer prognosis cannot be determined in a population-based study. Understanding the causative mechanisms may improve our understanding of the biology of MM as well as biomarkers associated with decreased overall survival in MM. Disclosures: Vij: Millennium: Speakers Bureau.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 774-774
Author(s):  
David Rein ◽  
Madeleine Hackney ◽  
Michele Dougherty ◽  
Camille Vaughan ◽  
Laurie Imhof ◽  
...  

Abstract The STEADI Options trial uses a randomized, controlled-trial design to assess the effectiveness and cost-effectiveness of the STEADI Initiative . Beginning March, 2020, we will randomize 3,000 adults ≥ 65 years of age at risk for falls seen in an Emory Clinic primary care practice to: (1) full STEADI; (2) a STEADI-derived gait, balance, and strength assessment with physical therapy referrals; (3) a STEADI-derived medication review and management; or (4) usual care. This presentation will discuss decisions made by the study team to facilitate implementation of STEADI including electronically conducting screening prior to the date of encounter, the use of dedicated nursing staff to conduct assessments, implementation of strength, balance, orthostatic hypotension, and vision testing, methods to facilitate medication review, and communication of assessment information to providers. The results from this study will be used to estimate the impact of STEADI on falls, service utilization, and costs over one year.


2018 ◽  
Vol 7 (11) ◽  
pp. 425 ◽  
Author(s):  
Kumar Jayant ◽  
Isabella Reccia ◽  
Francesco Virdis ◽  
A. Shapiro

Aim: The livers from DCD (donation after cardiac death) donations are often envisaged as a possible option to bridge the gap between the availability and increasing demand of organs for liver transplantation. However, DCD livers possess a heightened risk for complications and represent a formidable management challenge. The aim of this study was to evaluate the effects of thrombolytic flush in DCD liver transplantation. Methods: An extensive search of the literature database was made on MEDLINE, EMBASE, Cochrane, Crossref, Scopus databases, and clinical trial registry on 20 September 2018 to assess the role of thrombolytic tissue plasminogen activator (tPA) flush in DCD liver transplantation. Results: A total of four studies with 249 patients in the tPA group and 178 patients in the non-tPA group were included. The pooled data revealed a significant decrease in ischemic-type biliary lesions (ITBLs) (P = 0.04), re-transplantation rate (P = 0.0001), and no increased requirement of blood transfusion (P = 0.16) with a better one year graft survival (P = 0.02). Conclusions: To recapitulate, tPA in DCD liver transplantation decreased the incidence of ITBLs, re-transplantation and markedly improved 1-year graft survival, without any increased risk for blood transfusion, hence it has potential to expand the boundaries of DCD liver transplantation.


10.2196/12054 ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. e12054 ◽  
Author(s):  
Jennifer L Kraschnewski ◽  
Lan Kong ◽  
Erica Francis ◽  
Hsin-Chieh Yeh ◽  
Cindy Bryce ◽  
...  

Background Overweight and obesity are America’s number one health concern. The prevalence of obesity in the United States is greater than 36%, a rate that has doubled since 1970. As the second most preventable cause of death, obesity is a risk factor for diabetes, cardiovascular disease, stroke, and cancer, all major causes of death. Primary care clinics may be an ideal setting for weight control interventions to help manage and prevent diabetes. For this reason, the Centers for Medicare and Medicaid Services (CMS) implemented a health care procedure coding system code for intensive behavioral therapy (IBT) for obesity within primary care in 2012 to facilitate payment for addressing obesity, which was followed by broader coverage by most insurers for IBT for adults in 2013. However, the impact of this coverage on patient-centered outcomes is largely unknown. Objective The overarching goal of this study is to understand the comparative effectiveness of obesity counseling as covered by CMS and other insurers in improving weight loss for adults either with or at increased risk for type 2 diabetes. Methods This study leverages the novel infrastructure of the Patient-Centered Outcomes Research Institute–funded PaTH Clinical Data Research Network. The PaTH network is comprised of Geisinger Health System, Johns Hopkins University, Johns Hopkins Health System, Lewis Katz School of Medicine at Temple University, Temple Health System, Penn State College of Medicine, Penn State Milton S Hershey Medical Center, University of Pittsburgh, UPMC and UPMC Health Plan, and the University of Utah. Electronic health record (EHR) data will originate from the 6 PaTH health systems. Specifically, we will (1) evaluate the impact of broader preventive service coverage for obesity screening and counseling on weight loss, diabetes incidence, and diabetes outcomes in patients with diabetes or at increased risk for diabetes (defined by body mass index [BMI] ≥25). We will determine how the annual probability of receiving obesity and/or nutritional counseling changed pre- and postpolicy across all insurers in a cohort of patients with diabetes and at high risk for diabetes. We will (2) compare patient weight loss and diabetes-related outcomes among those who receive obesity screening and counseling with those who do not, following implementation of preventive service coverage. We will examine postpolicy impact of obesity screening and counseling in a cohort of patients with diabetes and at increased risk for diabetes. Specific outcomes to be examined include weight loss, diabetes incidence, and diabetes outcomes. Exploratory outcomes will include patient-reported outcomes. Furthermore, we will determine patient characteristics, including demographics, and practice characteristics, including provider type. Results Our PCORI-funded study is underway. To date, we have obtained our second data extraction from the PaTH CDRN and are performing data editing and cleaning. Next steps include analysis of early policy change. Conclusions Given patients who are overweight are at highest risk for diabetes, improved weight management services could prevent diabetes and its negative health outcomes. Comparing weight and diabetes outcomes in 3 states using EHRs and claims data before and after this policy was implemented using the PaTH Network will allow important insight into policy effectiveness. International Registered Report Identifier (IRRID) DERR1-10.2196/12054


2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  

Abstract Introduction Compared to the general population, in the postoperative period, surgical patients are both at increased risk of SARS-CoV-2 infection and increased mortality in the event of SARS-CoV-2 infection. This study modelled the impact of preoperative vaccination of patients aged ≥70 years having elective inpatient surgery. Method The primary outcome was the number needed to treat (NNT) to prevent one death over one year following SARS-CoV-2 vaccination. Postoperative SARS-CoV-2 incidence and adjusted mortality risk difference for SARS-CoV-2 infection were estimated from the prospective GlobalSurg-CovidSurg Week study (90,146 elective surgery patients across 1,595 hospitals in 115 countries), were used to estimate lives saved by vaccination in the first 30 postoperative days. SARS-CoV-2 case and death registration data from the Office for National Statistics was used to estimate NNTs for the general population. Best and worst-case scenarios were used to describe uncertainty around estimates. Results Among patients aged ≥70 years undergoing any type of surgery, NNT was estimated to be 332 (best case: 213; worst case: 690). NNT was lower in the cancer surgery subgroup (245 [150-545]). This was more favourable than the NNT for vaccination of the general population aged ≥70 (588 [403-1032]). Globally, vaccinating elective surgery patients aged ≥70 years preoperatively was projected to save 27,356 lives in one year compared to vaccinating the same patients after surgery. Conclusions Preoperative pathways should be set up for the vaccination of patients aged ≥70. In settings with limited vaccine availability, elective cancer surgery patients should be prioritised for vaccination.


PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0167577 ◽  
Author(s):  
Luciano Billodre Luiz ◽  
César Luis de Souza Brito ◽  
Letícia Manoel Debon ◽  
Lívia Nora Brandalise ◽  
Juliana Tainski de Azevedo ◽  
...  

Metabolism ◽  
2011 ◽  
Vol 60 (12) ◽  
pp. 1736-1740 ◽  
Author(s):  
Beatriz G.S. Seligman ◽  
Carisi A. Polanczyk ◽  
Angela S.B. Santos ◽  
Murilo Foppa ◽  
Mauricio Junges ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document